发明授权
- 专利标题： Compositions and their uses directed to HBXIP
- 专利标题（中）： 组合及其用途指向HBXIP
-
申请号： US12374635申请日： 2007-07-18
-
公开(公告)号： US08198253B2公开(公告)日： 2012-06-12
- 发明人: Kenneth W. Dobie , Nicholas M. Dean , C. Frank Bennett
- 申请人： Kenneth W. Dobie , Nicholas M. Dean , C. Frank Bennett
- 申请人地址： US CA Carlsbad
- 专利权人： Isis Pharmaceuticals, Inc.
- 当前专利权人： Isis Pharmaceuticals, Inc.
- 当前专利权人地址： US CA Carlsbad
- 代理机构： Jones Day
- 国际申请： PCT/US2007/073799 WO 20070718
- 国际公布： WO2008/011473 WO 20080124
- 主分类号： C07H21/02
- IPC分类号： C07H21/02 ; C07H21/04 ; A61K31/70 ; C12Q1/68
摘要：
Disclosed herein are compounds, compositions and methods for modulating the expression of HBXIP in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
公开/授权文献
- US20100056607A1 COMPOSITIONS AND THEIR USES DIRECTED TO HBXIP 公开/授权日：2010-03-04
信息查询
